AZN vs CDRE · P/E 28, $288.38B cap vs P/E 36, rev $362.6M
AstraZeneca PLC (AZN) versus Cadre Holdings Inc (CDRE) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Cadre Holdings Inc (CDRE) is a aerospace & defense company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported CDRE revenue for 2026-06-30 was $362.6M. Net income was $13.4M. CDRE currently screens at market cap $1.28B and trailing P/E 35.7.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. CDRE currently screens at market cap $1.28B and trailing P/E 35.7.
Not investment advice. Open the AZN and CDRE stock pages for the full models.
Not investment advice.